Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-ICE for Recurrent/Refractory Non-Hodgkin's Lymphoma
NCT00007865Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Sep 2000
- Primary completion
- Mar 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in non-Hodgkin lymphoma (NHL), sponsored by University of Nebraska. Started Sep 2000; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00007865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007865.